COSM NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Cosmos Health Inc. · Healthcare · Medical Distribution

Latest close 0.20 USD
-14.9% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -41.7% below the Trend Line and sits at 3.3% of its 52-week range. The latest completed week returned -14.9%, after a 16.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 56/100 conviction, while the latest news-sentiment score is 60/100. Near-term considerations: volume confirmation is below normal; earnings are due in 18d.

Setup score 28 out of 100
Latest Close 0.20 USD 24 Jul 2026
1W Return -14.9% latest completed week
4W Return 16.1% short-term follow-through
12W Return -47.3% quarterly tape
Trend Breadth 28.8% 15 of 52 weeks active
Volume Ratio 0.5x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 39.42% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -41.7% below the Trend Line and sits at 3.3% of its 52-week range. The latest completed week returned -14.9%, after a 16.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0612-week average 0.12

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.06Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 16.1% over four weeks, -47.3% over 12 weeks, and -71.3% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-14.9%
4W16.1%
12W-47.3%
26W-59.9%
52W-71.3%
Active trend streak0 weeks
Active weeks in one year15
Trend breadth28.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.38Latest activity-pressure read.
Pressure change372.2%Four-week change in activity pressure.
Leadership-66.59Latest relative-leadership reading.
RS change9.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength66/100Blend of value, momentum, and quality. Underlying universe rank 35; rank 1 is best.
Value57/100Relative valuation strength. Underlying universe rank 44; rank 1 is best.
Quality56/100Profitability and accounting quality. Underlying universe rank 45; rank 1 is best.
Momentum57/100Medium-term price momentum. Underlying universe rank 44; rank 1 is best.
Growth57/100Revenue and earnings growth. Underlying universe rank 44; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.2x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-36.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
10.4%
Gross profit retained from each unit of revenue.
Operating margin
-29.1%
Operating profit retained from revenue.
Free-cash-flow margin
-15.4%
Free cash flow generated from revenue.
Return on invested capital
-41.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
29.8%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-43.7%
Net share repurchases relative to market value.
Shareholder yield
-43.7%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

COSM shows volatility options pressure with a 56/100 conviction score, put-call volume ratio of 0.00, expected move of 52.1%, and Sharemaestro trend signal inactive.

Conviction56/100
Expected move52.1%
Put/call volume0.00
Pressure100
Speculation22
Volatility96
Trend agreement0
Open options detail
Insider activity10 / 7

10 acquisitions and 7 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment60/100

Weighted news tone is neutral across 60 relevant articles.

27 positive · 29 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings18dNext report is scheduled for 17 Aug 2026; event risk rises as the date approaches.
Options expected move52.1%Nearest-chain priced movement where available.
52-week drawdown-84.9%Distance below the 52-week high.
13-week volatility16.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher6 of 2620 weeks finished lower.
Best week+37.7%Week of 3 Jul.
Worst week-19.8%Week of 17 Jul.
Latest week-14.9%Week of 24 Jul.

Shape of recent returns

Strong gains4
Modest gains2
Flat weeks0
Modest losses7
Sharp losses13
Recent vol16.6%13-week weekly-return volatility.
Base vol14.2%52-week weekly-return volatility.
Up/down split16/35Count of positive and negative weeks in the 52-week window.
Average skew14.2% / -8.6%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20260.20 USD-14.9%0.34 USD0.74 USD0.38-66.5923.5MOff
17 Jul 20260.23 USD-19.8%0.35 USD0.74 USD0.32-62.1641.3MOff
10 Jul 20260.29 USD23.5%0.36 USD0.76 USD0.22-55.23122.3MOff
3 Jul 20260.24 USD37.7%0.37 USD0.77 USD-0.05-63.4473.8MOff
26 Jun 20260.17 USD-19.1%0.37 USD0.79 USD-0.14-73.4631.5MOff
19 Jun 20260.21 USD1.4%0.39 USD0.81 USD-0.03-69.01218.3MOff
12 Jun 20260.21 USD-16.3%0.41 USD0.83 USD-0.11-68.9627.0MOff
5 Jun 20260.25 USD1.5%0.42 USD0.85 USD-0.05-62.5111.2MOff
29 May 20260.25 USD-2.2%0.44 USD0.87 USD-0.04-65.136.0MOff
22 May 20260.25 USD-16.3%0.46 USD0.89 USD0.09-63.703.9MOff
15 May 20260.30 USD-9.2%0.48 USD0.91 USD0.20-56.577.9MOff
8 May 20260.33 USD-12.5%0.51 USD0.93 USD0.33-52.682.0MOff
1 May 20260.38 USD-0.1%0.53 USD0.95 USD0.09-43.413.2MOff
24 Apr 20260.38 USD-6.5%0.55 USD0.96 USD-0.23-42.904.9MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.